The BIO Asia International Conference in Tokyo brings together the global biotechnology and pharmaceutical industry to explore licensing collaborations and investor engagement in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market and throughout the region.  Companies with more than 460 therapeutic assets from more than 25 countries pursued Partnering discussions at the 2019 Tokyo conference.